Dr. Jon Word Blaschke is a Oklahoma City, Oklahoma based male rheumatologist who is specialized in Rheumatology. Active license number of Dr. Jon Word Blaschke for Rheumatology is 11711 in Oklahoma. Dr. Jon Word Blaschke treat joint disease similar to orthopedists but do not perform surgeries. He diagnose and treat diseases of joints, muscle, bones and tendons which includes arthritis, back pain, muscle strains, common athletic injuries and 'collagen' diseases.
Complete Profile:
Dr. Jon Word Blaschke speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Rheumatology
Credentials:
M.D.
Gender:
Male
Practice Address:
608 Nw 9th St, Suite 4204, Oklahoma City, Oklahoma, 73102-1049
Phone:
405-232-3095
Fax:
405-232-3094
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1275580268
NPI Enumeration Date:
27 May, 2006
NPI Last Update On:
28 Aug, 2008
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Jon Word Blaschke are as mentioned below.
License Number
Specialization
State
Status
11711
Rheumatologist
Oklahoma
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
608 Nw 9th St, Suite 4204 Oklahoma City, Oklahoma
Zip:
73102-1049
Phone Number:
405-232-3095
Fax Number:
405-232-3094
Patients can reach Dr. Jon Word Blaschke at 608 Nw 9th St, Suite 4204, Oklahoma City, Oklahoma or can call to book an appointment on 405-232-3095. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.